| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
HIQ Overview
HitIQ Limited develops and commercializes concussion management technology in Australia.
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.18 |
| 52 Week High | AU$0.12 |
| 52 Week Low | AU$0.30 |
| Beta | 0 |
| 1 Month Change | 19.36% |
| 3 Month Change | 12.12% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -19.56% |
Recent News & Updates
Shareholder Returns
| HIQ | AU Healthcare Services | AU Market | |
|---|---|---|---|
| 7D | 8.8% | 3.3% | 0.8% |
| 1Y | n/a | 46.5% | 24.4% |
Return vs Industry: Insufficient data to determine how HIQ performed against the Australian Healthcare Services industry.
Return vs Market: Insufficient data to determine how HIQ performed against the Australian Market.
Price Volatility
| HIQ volatility | |
|---|---|
| HIQ Beta | 0 |
| Industry Beta | 0.48 |
| Market Beta | 1 |
Stable Share Price: HIQ is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 9% a week.
Volatility Over Time: Insufficient data to determine HIQ's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2015 | 25 | Mike Vegar | https://hitiq.com |
HitIQ Limited develops and commercializes concussion management technology in Australia. The company offers Nexus A9 sensor to record individual head impacts. Its Nexus software delivers a platform for measuring and managing head impact exposures, as well as allows users to quantify exposures across individual players, positions, periods, and drills.
HITIQ Fundamentals Summary
| HIQ fundamental statistics | |
|---|---|
| Market Cap | AU$25.82m |
| Earnings (TTM) | -AU$5.06m |
| Revenue (TTM) | AU$406.68k |
60.3x
P/S Ratio-4.8x
P/E RatioIs HIQ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HIQ income statement (TTM) | |
|---|---|
| Revenue | AU$406.68k |
| Cost of Revenue | AU$3.34m |
| Gross Profit | -AU$2.93m |
| Expenses | AU$2.13m |
| Earnings | -AU$5.06m |
Last Reported Earnings
Jun 30, 2021
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.038 |
| Gross Margin | -720.12% |
| Net Profit Margin | -1,244.92% |
| Debt/Equity Ratio | 7.4% |
How did HIQ perform over the long term?
See historical performance and comparisonValuation
Is HITIQ undervalued compared to its fair value and its price relative to the market?
3.09x
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate HIQ's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate HIQ's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: HIQ is unprofitable, so we can't compare its PE Ratio to the Global Healthcare Services industry average.
PE vs Market: HIQ is unprofitable, so we can't compare its PE Ratio to the Australian market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate HIQ's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: HIQ is good value based on its PB Ratio (3.1x) compared to the AU Healthcare Services industry average (4.1x).
Future Growth
How is HITIQ forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
40.4%
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as HITIQ has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Past Performance
How has HITIQ performed over the past 5 years?
-93.3%
Last years earnings growth
Earnings and Revenue History
Quality Earnings: HIQ is currently unprofitable.
Growing Profit Margin: HIQ is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if HIQ's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare HIQ's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: HIQ is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (37.7%).
Return on Equity
High ROE: HIQ has a negative Return on Equity (-63.9%), as it is currently unprofitable.
Financial Health
How is HITIQ's financial position?
Financial Position Analysis
Short Term Liabilities: HIQ's short term assets (A$9.2M) exceed its short term liabilities (A$1.6M).
Long Term Liabilities: HIQ has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: HIQ's debt to equity ratio (7.4%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if HIQ's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: HIQ has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: HIQ has sufficient cash runway for more than 3 years if free cash flow continues to grow at historical rates of 19.4% each year
Dividend
What is HITIQ current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate HIQ's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate HIQ's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if HIQ's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if HIQ's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of HIQ's dividend in 3 years as they are not forecast to pay a notable one for the Australian market.
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
AU$764k
CEO Compensation
CEO
Mike Vegar
no data
Tenure
AU$764,044
Compensation
Mr. Michael Dean Vegar, also known as Mike, serves as Managing Director, Chief Executive Officer and Director at HITIQ LIMITED. Mr. Vegar is a co-founder of HitIQ. He has been responsible for creating and...
CEO Compensation Analysis
Compensation vs Market: Mike's total compensation ($USD572.75K) is above average for companies of similar size in the Australian market ($USD301.38K).
Compensation vs Earnings: Mike's compensation has increased whilst the company is unprofitable.
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: HIQ insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Ownership Breakdown
Dilution of Shares: HIQ only recently listed within the past 12 months.
Top Shareholders
Company Information
HITIQ Limited's employee growth, exchange listings and data sources
Key Information
- Name: HITIQ Limited
- Ticker: HIQ
- Exchange: ASX
- Founded: 2015
- Industry: Health Care Technology
- Sector: Healthcare
- Market Cap: AU$25.822m
- Shares outstanding: 132.42m
- Website: https://hitiq.com
Number of Employees
Location
- HITIQ Limited
- 9-17 Raglan Street
- Suite 1
- Melbourne
- Victoria
- 3205
- Australia
Listings
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2021/10/26 07:01 |
| End of Day Share Price | 2021/10/26 00:00 |
| Earnings | 2021/06/30 |
| Annual Earnings | 2021/06/30 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.